(S1 (S (NP (NN Anaplasma) (NN phagocytophilum))))
(S1 (S (NP (NN Classification))))
(S1 (S (NP (JJR Higher) (NN order) (NNS taxa))))
(S1 (S (NP (NNS Species))))
(S1 (S (NP (NP (NN Anaplasma) (NN phagocytophilum)) (: ;) (NP (NN Anaplasma) (NN marginale)) (: ;) (NP (NN Anaplasma) (NN platys-LRB-2-RRB-)))))
(S1 (S (NP (NP (NN Description)) (CC and) (NP (NN significance)))))
(S1 (S (S (NP (NN Anaplasma)) (VP (VBZ phagocytophilumis) (NP (DT an) (JJ intracellular) (JJ obligate) (NN pathogen)))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VP (VBZ is) (ADVP (RB widely)) (VP (VBN distributed))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (NP (NNP North) (NNP America)) (, ,) (NP (NNP Europe)) (, ,) (CC and) (NP (NNP Asia))))))))) (. .)))
(S1 (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VP (VBZ causes) (NP (DT the) (NN disease) (JJ human) (JJ granulocytic) (NN ehrlichiosis-LRB-HGE-RRB-))) (CC and) (VP (VBZ is) (ADVP (RBS most) (RB often)) (VP (VBN spread) (PP (IN through) (NP (NN tick) (NNS bites))))) (CC and) (VP (VBZ is) (ADVP (RB thus)) (ADVP (RB widely)) (VP (VBN studied)))) (. .)))
(S1 (S (S (NP (DT The) (NN bacterium)) (VP (VP (VBZ infects)) (CC and) (VP (VBZ colonizes) (NP (NNS neutrophils)) (PP (IN in) (NP (NN host) (NNS organisms))) (, ,) (S (ADVP (RB often)) (VP (VBG leading) (PP (TO to) (NP (NN immunodeficiency) (NN diseases-LRB-1-RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ human) (JJ granulocytic) (NN ehrlichiosis)) (NP (NN pathogen))) (VP (VBD was) (ADVP (RB first)) (VP (VBN described) (PP (IN in) (NP (NP (CD 1994)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN in) (NP (NP (NN Wisconsin)) (CC and) (NP (NN Minnesota-LRB-14-RRB-))))))))))) (. .)))
(S1 (S (S (NP (NP (NNS Ticks)) (VP (VBN collected) (PP (IN from) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (NN infection))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN discovered) (S (VP (TO to) (VP (VB be) (NP (NP (NNS carriers)) (PP (IN of) (NP (DT the) (JJ HGE) (NN pathogen-LRB-14-RRB-)))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ infectious) (NN agent)) (, ,) (VP (ADVP (RB first)) (VBN classified) (PP (IN as) (NP (NN Ehrlichia) (NN phagocytophila))))) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN reclassified) (PP (IN as) (NP (NN Anaplasma) (NN phagocytophilum-LRB-14-RRB-))))))) (. .)))
(S1 (S (NP (NP (NN Cell) (NN structure)) (CC and) (NP (NN metabolism)))))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ is) (NP (NP (DT a) (JJ small) (JJ gram-negative) (NN bacterium)) (PP (IN of) (NP (NN 0.2-2) (NN micrometer) (CD diameter-LRB-5-RRB-)))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VP (VBZ is) (NP (DT a) (JJ obligate) (JJ intracellular) (NN pathogen))) (CC and) (VP (VBZ replicates) (PP (IN within) (NP (DT a) (NN host) (NN cell) (NN vacuole))) (S (VP (TO to) (VP (VB form) (NP (DT a) (NN morula) (NN microcolony-LRB-5-RRB-)))))))) (. .)))
(S1 (S (S (PP (IN On) (NP (NP (DT the) (NN membrane) (NN surface)) (PP (IN of) (NP (NN Anaplasma) (NN phagocytophilum))))) (VP (MD can) (VP (VB be) (VP (VBD found) (NP (NP (PRP$ its) (JJ major) (JJ antigenic) (NN membrane) (NNS proteins)) (, ,) (NP (NP (NN p44)) (CC and) (NP (NN msp2))) (, ,) (SBAR (WHNP (NP (DT both)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (ADJP (RB approximately) (JJ 44-kDa) (PP (IN in) (NP (NN size-LRB-13-RRB-)))))))))))) (. .)))
(S1 (S (S (NP (DT These) (CD two) (NN membrane) (NNS proteins)) (VP (VBP play) (NP (DT a) (JJ vital) (NN role)) (PP (IN in) (NP (NP (NN Anaplasma) (NN phagocytophilum)) (NN virulence))))) (. .)))
(S1 (S (S (NP (DT The) (NN bacterium)) (VP (VBZ has) (NP (NP (DT a) (NN Type-IV) (NN secretion) (NNS apparatus)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB transfer) (NP (NNS materials)) (PP (IN between) (NP (NP (PRP itself)) (CC and) (NP (DT the) (NN host-LRB-12-RRB-)))))))))))))) (. .)))
(S1 (S (S (PP (IN Unlike) (NP (JJ many) (JJ gram-negative) (NNS bacteria))) (, ,) (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ lacks) (NP (NP (DT a) (NN peptidoglycan) (NN layer)) (PP (IN on) (NP (PRP$ its) (JJ outer) (NN membrane-LRB-7-RRB-)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP it)) (VP (VBZ lacks) (NP (NP (DT the) (NNS genes)) (ADJP (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN biosynthesis)) (PP (IN of) (NP (NP (NN lipid) (NN A)) (CC and) (NP (NN peptidoglycan)))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (ADJP (RB very) (JJ fragile)) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB highly) (JJ susceptible) (PP (TO to) (NP (NN stress-LRB-7-RRB-))))))))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ is) (NP (NP (DT a) (NN disease)) (VP (VBG causing) (NP (JJ intracellular) (NN bacterium)) (PP (IN in) (NP (NP (NNS dogs)) (, ,) (NP (NNS humans)) (, ,) (NP (NNS horses)) (CC and) (NP (NN ruminants-LRB-3-RRB-)))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ lacks) (NP (NN lipopolysaccharide) (JJ biosynthetic) (NN machinery-LRB-12-RRB-)))) (. .)))
(S1 (S (S (NP (DT The) (NNS bacteria)) (VP (VBP reside) (PP (IN in) (NP (NP (NN host) (NNS endosomes)) (SBAR (WHADVP (WRB whereby)) (S (NP (PRP they)) (VP (VB obtain) (NP (NP (DT the) (NNS nutrients)) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VBP carry) (PRT (RP out)) (NP (JJ binary) (NN fission-LRB-12-RRB-)))))))))))))) (. .)))
(S1 (S (S (PP (JJ Due) (TO to) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB synthesize) (NP (NN peptidoglycan))))))))) (, ,) (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ relies) (PP (IN on) (NP (NN membrane) (NN cholesterol))) (S (VP (TO to) (VP (VB maintain) (NP (JJ physical) (NN integrity-LRB-7-RRB-))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (ADVP (RB also)) (VP (VBZ lacks) (NP (NP (NNS genes)) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NP (NN biosynthesis)) (CC or) (NP (NN modification))) (PP (IN of) (NP (NP (NN cholesterol)) (CC or) (NP (JJ related) (NN sterols-LRB-7-RRB-)))))))))) (. .)))
(S1 (S (S (NP (DT All) (NNS cholesterols)) (VP (VBP are) (ADVP (RB therefore)) (VP (VBP are) (ADVP (RB directly)) (VP (VBN taken) (PP (IN from) (NP (NP (JJ exogenous) (NNS sources)) (PP (IN without) (NP (NP (JJ extensive) (NN modification)) (PP (IN before) (NP (NP (NN incorporation)) (PP (IN into) (NP (DT the) (NN membrane-LRB-7-RRB-))))))))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VBP carry) (PP (IN out) (NP (NP (JJ major) (JJ metabolic) (NNS pathways)) (PP (VBG including) (NP (NP (NN glycolysis)) (, ,) (NP (DT the) (JJ citric) (NN acid) (NN cycle)) (CC and) (NP (DT the) (JJ pentose) (NN phosphate) (NN pathway-LRB-16-RRB-)))))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB metabolize) (NP (NP (NNS saccharides)) (PP (JJ such) (IN as) (NP (NP (NP (NN pentose)) (, ,) (NP (NN fructose)) (CC and) (NP (NN mannose))) (PP (IN into) (NP (JJ metabolic) (NN intermediates-LRB-16-RRB-)))))))))))) (. .)))
(S1 (S (NP (NN Ecology))))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ is) (VP (VBN distributed) (ADVP (RB widely)) (PP (IN throughout) (NP (JJ vast) (JJ geographical) (NNS regions)))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NNP North) (NNP America))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RBS most) (JJ common) (PP (IN in) (NP (NP (DT the) (JJ north-east) (, ,) (JJ upper) (NN Midwest) (CC and) (NN northern) (NN California)) (PP (IN in) (NP (DT the) (JJ United) (NN States-LRB-5-RRB-)))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN discovered) (PP (IN in) (NP (JJ several) (NP (NNP European)) (CC and) (NP (NNP Asian)) (NP (NN countries-LRB-1-RRB-))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ prevalent) (PP (IN in) (NP (NP (NNS regions)) (PP (IN with) (NP (ADJP (JJ tropical) (TO to) (JJ sub-trophical)) (NN climate) (-LRB- -LRB-) (CD 10) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (MD can) (VP (VB be) (ADVP (RB successfully)) (VP (VBN cultured) (PP (IN at) (NP (CD 37) (NNS degrees) (NN Celcius-LRB-Park-RRB-))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ primary) (NN host) (IN of) (NN Anaplasma) (NN phagocytophilum)) (PP (IN in) (NP (NNP North) (NNP America)))) (VP (VBZ is) (NP (NP (DT the) (JJ white-footed) (NN mouse)) (PP (IN with) (NP (NP (JJ human) (NNS beings)) (PP (IN as) (NP (ADJP (RB merely) (JJ accidental)) (NN hosts-LRB-9-RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (DT A) (JJ wide) (NN range)) (PP (IN of) (NP (NP (NNS mammals)) (PP (JJ such) (IN as) (NP (NP (NNS horses)) (, ,) (NP (NNS cows)) (, ,) (CC and) (NP (NN sheep))))))) (VP (MD can) (VP (VB serve) (PP (IN as) (NP (NP (NN host)) (PP (IN for) (NP (DT the) (NN bacterium-LRB-5-RRB-)))))))) (. .)))
(S1 (S (NP (NN Pathology))))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ is) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (JJ Human) (JJ granulocytic) (NN ehrlichiosis)))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT a) (JJ prevalent) (JJ human) (NN tickborne) (NN zoonosis)) (PP (IN of) (NP (DT the) (NNS neutrophils)))) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (NP (DT The) (NN pathogen)) (VP (VBZ persists) (PP (IN within) (NP (DT the) (JJ polymorphonuclear) (NN leucocytes-LRB-1-RRB-))))) (. .)))
(S1 (S (S (NP (DT The) (NN disease)) (VP (VBD was) (ADVP (RB first)) (VP (VBN identified) (PP (IN in) (NP (CD 1990))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN in) (NP (NP (NNP Wisconsin)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (NP (NN Anaplasma) (NN phagocytophilum) (NN infection)) (PP (IN in) (NP (NNS humans)))) (VP (VBZ delays) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NNS neutrophils)))))) (, ,) (S (VP (VBG allowing) (PP (IN for) (NP (NP (ADJP (RBR more) (JJ effective)) (NNS infections)) (PP (IN of) (NP (DT the) (NN neutrophils-LRB-5-RRB-))))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (ADVP (RB also)) (VP (VBZ causes) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN IL-8)) (, ,) (NP (NP (DT a) (NN neutrophil) (NN chemoattractant)) (SBAR (WHNP (WDT that)) (S (VP (VBZ increases) (NP (NP (DT the) (NN phagocytosis)) (PP (IN of) (NP (NNS neutrophils))))))))))))) (. .)))
(S1 (S (S (NP (NNS Studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ is) (S (VP (TO to) (VP (VB increase) (NP (NP (NN bacterium) (NN dissemination)) (PP (IN into) (NP (NN neutrophils-LRB-5-RRB-)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT These) (NNS permutations)) (PP (TO to) (NP (DT the) (NNS neutrophils)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (JJ immunological) (NNS changes)) (, ,) (S (VP (VBG making) (S (NP (DT the) (NN host)) (ADJP (RBR more) (JJ susceptible) (PP (TO to) (NP (JJ opportunistic) (NN infections-LRB-1-RRB-)))))))))))) (. .)))
(S1 (S (S (NP (JJ Human) (JJ granulocytic) (NN anaplasmosis)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by))))) (, ,) (CC but) (RB not) (S (ADJP (JJ limited) (PP (TO to))) (, ,) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NP (NN malaise)) (, ,) (NP (NN fever)) (, ,) (NP (NN myalgia)) (, ,) (NP (NN headache)) (, ,) (NP (NP (NP (JJ gastrointestinal) (NN tract)) (NN involvement)) (PRN (-LRB- -LRB-) (NP (NP (NN nausea)) (, ,) (NP (NN vomiting)) (, ,) (NP (NN diarrhea))) (-RRB- -RRB-))) (CC and) (NP (NP (NN involvement)) (PP (IN of) (NP (NP (DT the) (JJ respiratory) (NN tract)) (PRN (-LRB- -LRB-) (NP (NN cough)) (, ,) (NP (JJ pulmonary) (NNS infiltrates)) (-RRB- -RRB-)))))))) (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-))) (. .)))
(S1 (S (S (NP (NP (JJ Other) (NNS injuries)) (PP (TO to) (NP (DT the) (NN body)))) (ADVP (RB sometimes)) (VP (VBP include) (NP (NP (NN skin) (NN rash)) (, ,) (NP (NN leukopenia)) (, ,) (NP (NN thrombocytopenia)) (, ,) (CC and) (NP (NP (NN damage)) (PP (TO to) (NP (DT the) (NN liver-LRB-1-RRB-))))))) (. .)))
(S1 (S (S (NP (NN Anaplasma) (NN phagocytophilum)) (ADVP (RB also)) (VP (VBZ causes) (NP (NP (NN ehrlichiosis)) (PP (IN in) (NP (NP (JJ other) (NNS species)) (PP (VBG including) (NP (NP (JJ domesticated) (NNS animals)) (PP (JJ such) (IN as) (NP (NP (NNS horses)) (, ,) (NP (NN sheep)) (, ,) (CC and) (NP (NN cattle) (-LRB- -LRB-) (CD 10) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (ADVP (JJ Similar) (PP (TO to) (NP (JJ human) (JJ granulocytic) (NN anaplasmosis)))) (, ,) (NP (NP (DT these) (NNS forms)) (PP (IN of) (NP (NN anaplasmosis)))) (VP (VBP are) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (NN bacterium)) (VP (VBN transmitted) (PP (IN via) (NP (NP (NN tick) (NNS bites)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (NP (JJ Current) (NN Research))))
(S1 (S (S (ADVP (RB Currently)) (NP (NN research)) (VP (VBZ is) (VP (VBG being) (VP (VBN conducted) (PP (IN with) (NP (NP (NNS regards)) (PP (TO to) (NP (NP (DT the) (NN AnkA) (NN gene)) (PP (IN in) (NP (NN Anaplasma) (NN phagocytophilum))))))))))) (. .)))
(S1 (S (S (NP (NN AnkA)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ 153-160kDa) (NN protein)) (PP (IN with) (NP (CD 11) (JJ N-terminal) (NN ankyrin) (NNS repeats)))) (CC and) (NP (NP (DT a) (NN C-terminus)) (PP (IN with) (NP (JJ several) (JJ tandem) (NN repeats-LRB-17-RRB-))))))) (. .)))
(S1 (S (S (ADVP (RB Currently)) (, ,) (NP (NN AnkA)) (VP (VBZ is) (NP (NP (DT the) (JJ only) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN secreted) (PP (IN by) (NP (NN Anaplasma) (NN phagocytophilum))))))))) (CC and) (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (ADJP (JJ instrumental) (PP (IN in) (NP (NP (DT the) (NN infection)) (PP (IN of) (NP (NNS neutrophils))))))))))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NN AnkA)) (VP (VP (VBZ leaves) (NP (DT the) (NN bacterium)) (PP (IN via) (NP (PRP$ its) (NN type) (CD IV) (NN secretion) (NNS apparatus)))) (CC and) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (JJ nuclear) (NNS proteins)) (PP (IN of) (NP (NN neutrophils-LRB-17-RRB-)))))))))))) (. .)))
(S1 (S (S (NP (NN AnkA)) (VP (VBZ varies) (PP (IN among) (NP (NP (JJ different) (NNS strains)) (PP (IN of) (NP (NN Anaplasma) (NN phagocytophilum))))) (SBAR (IN although) (S (NP (JJ different) (NNS populations)) (VP (VBP maintain) (NP (NP (NNS regions)) (PP (IN of) (NP (NN conservation-LRB-17-RRB-))))))))) (. .)))
(S1 (S (S (ADVP (RB Currently)) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ geological) (NN variation)) (PP (IN of) (NP (NN AnkA))))) (PP (IN on) (NP (PRP$ its) (NN function)))) (VP (VBZ is) (ADJP (JJ unknown)) (S (NP (NN Research)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN conducted) (PP (IN into) (NP (NP (DT the) (NNS methods)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (NP (NN Anaplasma) (NN phagocytophilum)) (VP (VBZ resists) (NP (DT the) (JJ immune) (NN system)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ primary) (NN method)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (NP (NNS neutrophils)) (VP (NN attack) (NP (NNS pathogens)))))) (VP (VBZ is) (PP (IN via) (NP (NP (DT the) (NN superoxide) (NN anion)) (, ,) (VP (VBN produced) (PP (IN by) (NP (DT the) (NN NADPH) (NN oxidase) (CD complex-LRB-15-RRB-)))))))) (. .)))
(S1 (S (S (ADVP (RB However)) (, ,) (PP (ADVP (RB once)) (IN within) (NP (DT the) (NN host) (NN cell))) (, ,) (NP (NN Anaplasma) (NN phagocytophilum)) (ADVP (RB rapidly)) (VP (VP (VBZ detoxifies) (NP (DT the) (NN superoxide)) (PP (IN via) (NP (DT a) (ADJP (RB still) (JJ unknown)) (NN method)))) (CC and) (VP (VBZ resides) (PP (IN within) (NP (NP (DT a) (JJ protective) (NN vacuole)) (SBAR (WHNP (WDT that)) (S (VP (VBZ segregates) (NP (PRP it)) (PP (IN from) (NP (NN superoxide) (NN anions-LRB-15-RRB-))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN superoxide) (NN anion) (NN resistance)))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN discovered))))))) (. .)))
(S1 (S (S (NP (NN Research)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN conducted) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (NP (JJ serological) (NN interaction)) (PP (IN between) (NP (NP (NN Anaplasma) (NN phagocytophilum)) (CC and) (NP (NN Anaplasma) (NN marginale))))))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN noted) (SBAR (IN that) (S (PP (IN in) (NP (NP (NP (NN cattle)) (CC and) (NP (NNS horses))) (VP (VBN exposed) (PP (TO to) (NP (NN Anaplasma) (NN marginale)))))) (, ,) (NP (NP (NNS antibodies)) (PP (TO to) (NP (FW A.) (FW phagocytophilum)))) (VP (VBD were) (ADVP (RB also)) (NP (NN produced-LRB-10-RRB-)))))))) (. .)))
(S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (NP (NN cattle)) (CC and) (NP (NP (NNS horses)) (VP (VBN exposed) (PP (TO to) (NP (FW A.) (FW phagocytophilum)))))) (ADVP (RB also)) (VP (VBP produce) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NNP A.) (CD marginale-LRB-10-RRB-)))))) (. .)))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (ADJP (RB currently) (JJ serological)) (NN testing) (NNS methods)) (VP (VBP are) (ADVP (RB presently)) (PP (IN under) (NP (NN evaluation))) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP lack) (NP (NN specificity))))))) (. .)))
